Apex Pharma

Apex Pharma, a UK supplier of research peptides and Retatrutide pens

Apex Pharma operates as a UK-focused supplier of research peptides and compounds, distributed in vial and pen formats. The company presents its catalogue as material intended exclusively for controlled laboratory, analytical and scientific research, and states that its products are not medicines, foods or supplements and are not authorised for human or veterinary use. Orders are handled directly by its own team rather than through marketplaces or overseas sellers, and stock is held and dispatched from within the United Kingdom.

Retatrutide presentations: Reta Pen 20mg and 40mg

The central product line is the Retatrutide pen, offered in two pre-mixed presentations. Retatrutide is described as an investigational synthetic peptide studied for its activity across three receptor pathways: GLP-1, GIP and glucagon. The company stresses that the compound remains investigational and is not an authorised medicine.

• Reta Pen 20mg UK: a 20mg research presentation supplied for controlled laboratory, analytical and scientific research.
• Reta Pen 40mg: a 40mg presentation aimed at research customers requiring a higher total quantity.
• Reta 20mg: the same compound in vial format.

Each presentation is presented with its stated quantity, batch information and, where applicable, analytical documentation, so that researchers can assess it against the requirements of their programme.

Other compounds in the catalogue

Beyond Retatrutide, the range includes other research peptides and ancillary items. The best-seller list shown on the site at the time of writing included:

• BPC 10mg
• MOTS-c 20mg
• Bac Water 10ml (bacteriostatic water)

The company describes the catalogue as growing and organised around laboratory and scientific research rather than consumer healthcare.

Testing, documentation and transparency

Apex Pharma states that selected products are assessed by independent laboratories to confirm characteristics such as identity and purity. It names Janoshik Analytical as the third-party laboratory behind its testing reports, and indicates that certificates of analysis and independent analytical reports may be available for selected products and batches. Where a report exists, the company says it is published online and linked to the corresponding product or batch, so that testing information can be reviewed alongside the item.

Ordering, delivery and customer base

The company supplies eligible individual researchers, laboratories, research organisations and procurement teams, and requires customers to have appropriate facilities and procedures for handling and storing research materials. Orders are packaged to protect products in transit, and UK delivery is free on orders over £100, subject to the delivery terms and any restrictions shown at checkout. Because stock is held domestically, the company presents fulfilment as avoiding overseas customs delays.

Research-use conditions and sales policy

Apex Pharma frames every product as supplied for legitimate laboratory and scientific research only. Buyers must be aged 18 or over and are responsible for ensuring that purchase, possession, storage, handling and use comply with the laws, regulations and institutional requirements applicable in their location. The company states that its products must not be consumed, administered or applied for treatment, diagnosis or any other clinical purpose, and that it does not accept liability for misuse, unauthorised use, improper storage or incorrect handling. Due to the specialist nature of the materials, all sales are described as final, with returns or refunds only where required by law. Storage requirements vary by compound and format, and the company directs users to the product label, certificate of analysis or accompanying technical documentation.